Best Bladder cancer Doctors in Turkey for Australians

Professor Bulent Karagoz is a leading medical oncologist at Anadolu Medical Center, specialising in immunotherapy and targeted therapies for bladder cancer.

• Focuses on tumour immunology to help the immune system identify and destroy cancer cells
• Uses targeted therapies that attack specific molecules in cancer cells to limit damage to healthy tissue
• Published over 40 research papers on tumour biology and clinical cancer research
• Former Head of Medical Oncology at GATA Haydarpasa Training Hospital
• Member of the Turkish Medical Oncology Association and the European Head and Neck Society

Professor Ilker Tinay is the Head of Uro-oncology at Anadolu Medical Center, a hospital affiliated with Johns Hopkins Medicine.

• Specialises in neo-bladder reconstruction, creating a new bladder from intestinal tissue after removal
• Expert in minimally invasive bladder surgery to reduce scarring and speed up recovery
• Serves as Secretary of the Bladder Tumours Research Group for the Association of Urooncology
• Active member of the International Bladder Cancer Network and American College of Surgeons
• Recognised with the Urooncology Association Scientific Research Award

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental in Istanbul. He completed a fellowship at the prestigious Hacettepe University Cancer Institute. Dr. Solak previously practiced at The University of Texas MD Anderson Cancer Center. He treats a variety of complex cancers, including lung, breast, and gastrointestinal malignancies.

• Specializes in the treatment of testicular, ovarian, and head and neck cancers.
• Performs oncology procedures including chemotherapy, immunotherapy, and targeted therapy.
• Trained at Hacettepe University and Istanbul Sisli Etfal Training Hospital.
• Practices at a JCI-accredited facility that treats over 500,000 patients annually.

Dr Eda Tanrikulu is a senior medical oncologist at Anadolu Medical Center with a focus on targeted chemotherapy for urological cancers. She ranked 3rd nationwide in Turkey's prestigious medical specialty exams before joining this Johns Hopkins-affiliated facility.

• Specialises in chemotherapy and personalised drug protocols for bladder cancer cases
• Lead researcher in international clinical studies testing new cancer treatments
• Completed specialised training at Oxford University in metastatic cancer management
• Member of the American Society of Clinical Oncology (ASCO)
• Former head of the medical oncology unit at a major training hospital

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Professor Sezer Sağlam leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital, bringing senior academic expertise to complex bladder cancer cases.

• Specialises in medical oncology at a JCI-accredited centre of excellence
• Member of the European Society for Medical Oncology (ESMO)
• Member of the American Society of Clinical Oncology (ASCO)
• Focuses on systemic treatments for gastrointestinal and urological tumours
• Trained at Istanbul University Oncology Institute, a leading Turkish research facility

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Professor Sefik Igdem is a senior radiation oncologist at Gayrettepe Florence Nightingale Hospital, where he leads the implementation of precision radiotherapy. He focuses on integrating high-end imaging with radiation to treat complex tumours.

• Specialises in conformal treatments that shape radiation beams to the exact size of the tumour
• Uses TrueBeam STx technology for precise delivery, protecting healthy organs near the bladder
• Utilises Halcyon systems for faster treatment sessions and improved patient comfort
• Serves as a Professor at Demiroglu Bilim University, training the next generation of specialists

Dr. Yahya Ozel is a general surgeon at Estexper Clinic in Istanbul. He has performed over 12,000 procedures during his career. Dr. Ozel specializes in bariatric, metabolic, and oncological surgery. He completed training at Tokyo University Hospital in Japan. This training focused on complex liver and pancreatic surgery.

• Performed over 5,000 bariatric and 2,500 metabolic surgeries.
• Placed more than 4,000 gastric balloons for weight loss.
• Treats gastrointestinal cancers, including stomach, colon, and liver cancer.
• Holds the Turkish Surgical Proficiency Certificate.

Dr. Emine Yildirim is an associate professor of general surgery at Atlas University Hospital, Istanbul. She specializes in surgical oncology with a focus on breast cancer treatment and reconstruction. Dr. Yildirim has published over 15 scientific articles in peer-reviewed journals like Academic Radiology. She holds multiple international certificates in breast cancer surgery and nipple-sparing techniques.

• Performs breast-conserving surgery, free flap reconstruction, and implant-based breast augmentation.
• Treats complex oncological conditions including thyroid, bladder, and colorectal cancers.
• Completed medical residency at Istanbul Haseki Health Application and Research Center.
• Works at AACI-accredited Atlas University Hospital, which treats 565,000 patients annually.

Professor Sinan Karaaslan is a specialist medical oncologist at the JCI-accredited Anadolu Medical Center, where he leads the medical management of urogenital system cancers.

• Specialises in treating urothelial carcinoma – the most common form of bladder cancer
• Fellowship trained in medical oncology at the prestigious Istanbul University Cerrahpaşa Medical Faculty
• Consults as part of a multidisciplinary uro-oncology team for complex cases
• Active member of the Turkish Medical Oncology Society and Turkish Lung Cancer Society

Professor Keskin ranked first in Turkey's national oncology proficiency exam and leads the oncology department at Memorial Şişli Hospital.

• Specialises in immunotherapy and targeted therapy to attack cancer cells while sparing healthy tissue
• Uses personalised medicine protocols for patients with advanced or complex bladder tumours
• Member of the American Society of Clinical Oncology (ASCO)
• Awarded for clinical research at the National Cancer Congress
• International expert in coordinating systemic treatments with surgical teams

Professor Yesim Yildirim is a leading medical oncologist at Anadolu Medical Center, specialising in immunotherapy and targeted treatments for malignant tumours.

• Trained at the Mount Vernon Cancer Centre in London specifically in immuno-oncology
• Holds an ESMO attestation certificate, the gold standard for European medical oncology expertise
• Contributed to major textbooks on precision medicine and advanced cancer care protocols
• Member of the European School of Oncology and the European Society of Medical Oncology

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Professor Sezer Saglam is a leading medical oncologist at Istanbul Florence Nightingale Hospital with senior expertise in managing complex tumour cases.

• Specialises in medical oncology at one of Turkey's premier JCI-accredited hospitals
• Expert in gastrointestinal oncology, focusing on cancers affecting the urinary and digestive systems
• Member of the American Society of Clinical Oncology (ASCO)
• Maintains active membership with the European Society for Medical Oncology (ESMO)
• Trained at Istanbul University Oncology Institute, a major centre for cancer research

Saban Sec serves as the specialist physician representative for the Turkish Medical Oncology Association, leading the way in urogenital cancer care.

• Specialises in medical oncology for bladder and other urogenital cancers
• Expert in managing chemotherapy and targeted immunotherapy protocols
• Published researcher in prognostic factors for complex tumour cases
• Member of the Turkish Medical Oncology Association and Istanbul Medical Chamber